Integrative Multi-Omics Prioritization Reveals Novel Urticaria Susceptibility Genes and Implicates a Potential C4A-CCL19 Relationship
Urticaria is a common and heterogeneous inflammatory skin disorder with a complex pathogenesis, and effective treatment options remain limited for some patients. This study employed an integrative multi-omics framework combining Mendelian randomization (MR), summary-data-based MR (SMR), Bayesian colocalization, and mediation analysis to identify candidate genes and inflammatory mediators associated with urticaria susceptibility. By leveraging expression quantitative trait locus (eQTL) data from blood and skin tissues alongside genome-wide association study (GWAS) summary statistics, seven candidate genes associated with urticaria susceptibility were prioritized. Notably, ARHGAP39, ATP7B, and C4A were genetically associated with a lower risk of urticaria, whereas CBLB, COBLL1, CYP21A2, and YIPF5 were associated with increased disease risk. Moreover, genetically predicted C4A expression was positively associated with circulating CCL19 levels, whereas genetically predicted CYP21A2 expression was inversely associated with CCL19 levels. Mediation analysis quantified that CCL19 accounted for 15.07% and 24.77% of the association of genetically predicted C4A and CYP21A2 expression with urticaria risk, respectively. Furthermore, C4A expression was significantly downregulated in lesional skin from patients with chronic spontaneous urticaria (CSU), and a consistent reduction was observed in ear skin from mice subjected to IgE/DNP-induced passive cutaneous anaphylaxis. Collectively, these findings support potential associations of C4A and CCL19 with urticaria risk and provide preliminary statistical evidence for a possible mediating role of CCL19 in the association between genetically predicted C4A expression and urticaria risk. Although this study cannot establish causality or directly inform clinical translation, it identifies candidate genes and a potential C4A–CCL19 relationship warranting experimental validation.
Authors
- Yuhao Zhao (ORCID: https://orcid.org/0000-0003-3999-8253)
- Yiqun Zhu
- Xiaoqing Yi
Institutions
- Central South University (CN)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/ijms272210129
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Hunan Province